111 Price to Free Cash Flow Ratio 2018-2024 | YI
111 Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-11-21 | 0.61 | 19.65 | |
2024-06-30 | 1.07 | $0.03 | 34.13 |
2024-03-31 | 1.16 | $-0.37 | 0.00 |
2023-12-31 | 1.55 | $-0.76 | 0.00 |
2023-09-30 | 2.60 | $-0.35 | 0.00 |
2023-06-30 | 2.46 | $-0.39 | 0.00 |
2023-03-31 | 2.65 | $-0.18 | 0.00 |
2022-12-31 | 3.02 | $-0.09 | 0.00 |
2022-09-30 | 2.68 | $-0.87 | 0.00 |
2022-06-30 | 2.06 | $-1.10 | 0.00 |
2022-03-31 | 2.66 | $-1.07 | 0.00 |
2021-12-31 | 3.50 | $-1.42 | 0.00 |
2021-09-30 | 6.17 | $-1.04 | 0.00 |
2021-06-30 | 9.09 | $-0.01 | 0.00 |
2021-03-31 | 13.80 | $-0.47 | 0.00 |
2020-12-31 | 6.95 | $-0.16 | 0.00 |
2020-09-30 | 6.20 | $0.07 | 88.32 |
2019-09-30 | 4.87 | $-0.35 | 0.00 |
2019-06-30 | 5.56 | $-0.83 | 0.00 |
2019-03-31 | 6.49 | $-0.45 | 0.00 |
2018-09-30 | 13.52 | $-0.54 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.052B | $2.105B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $8.263B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
Enovis (ENOV) | United States | $2.580B | 17.49 |
Privia Health (PRVA) | United States | $2.530B | 210.80 |
IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
Azenta (AZTA) | United States | $2.227B | 111.05 |
Omnicell (OMCL) | United States | $2.043B | 66.83 |
Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
10x Genomics (TXG) | United States | $1.609B | 0.00 |
Schrodinger (SDGR) | United States | $1.484B | 0.00 |
Phreesia (PHR) | United States | $1.098B | 0.00 |
Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
Standard BioTools (LAB) | United States | $0.603B | 0.00 |
Talkspace (TALK) | United States | $0.559B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
Pulmonx (LUNG) | United States | $0.254B | 0.00 |
TruBridge (TBRG) | United States | $0.239B | 69.61 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
American Well (AMWL) | United States | $0.123B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
HeartBeam (BEAT) | United States | $0.075B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Outset Medical (OM) | United States | $0.040B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
Zepp Health (ZEPP) | China | $0.038B | 0.00 |
Movano (MOVE) | United States | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |